<p>The present invention relates to novel hypocholesterolemic compounds of formula I <CHEM> useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels as well as to pharmaceutical compositions comprising said compounds alone or in combination with other active agents</p>
